Life Sciences

Concilio

University of Chicago

Concilio has developed a nanoparticle platform that effectively delivers therapeutic nucleotides to cells of interest to more effectively treat cardiovascular and pulmonary diseases.

This company will be presenting on Day 3 of DeepTechU 2022. View schedule >>